| 1. |
de Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis [Ｊ]. Br J Surg， 1996; 83(8)∶1071.
|
| 2. |
McKay CJ, Gallagher H, Brooks B, et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis [Ｊ]. Br J Surg， 1996; 83(7)∶919.
|
| 3. |
de Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis [Ｊ]. Br J Surg， 1996; 83(3)∶349.
|
| 4. |
崔潤林. 5Fu治療急性胰腺炎的初步觀察 [Ｊ]. 實用內科雜志， 1983； 3（5）∶246.
|
| 5. |
譚下宇 . 5氟尿嘧啶配合腹腔引流治療急性胰腺炎的初步體會 [Ｊ]. 中華醫學雜志, 1985； 65（12）∶757.
|
| 6. |
Saarrio IA. 5fluorouracil in the treatment of acute pancreatitis [Ｊ]. Am J Surg,1983; 145(3)∶349.
|
| 7. |
Kimura K,Shimosegawa T,Sasano H，et al.Endogenous glucocorticoids decrease the acinar cell sensitivity to apoptosis during cerulein pancreatitis in rats [Ｊ].Gastroenterology,1998; 114(2)∶372.
|
| 8. |
Darville T， Giroir B， Jacobs R. The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy [Ｊ]. Infection, 1993; 21(5)∶279.
|
| 9. |
Schlag G, Redl H. Mediators of injury and inflammation [Ｊ]. World J Surg,1996； 20(4)∶406.
|
| 10. |
Dinarello CA， Gelfand JA， Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome [Ｊ]. JAMA,1993; 269(14)∶1829.
|
| 11. |
Iwagaki H，Hizuta A， Uomoto M，et al. Clinical value of cytokine antagonists in infectious complications [Ｊ].Res Commun Mol Pathol Pharmacol, 1997； 96(1)∶25.
|
| 12. |
Artels H, Zantl N, Holzmann B, et al. Special therapeutic approaches for interrupting the cascadefrom SIRS to MOF [Ｊ]. Langenbecks Arch Chir Suppl Kongressbd, 1988; 115∶615.
|
